Document is current
Any future updates will be listed below
-
Authors
Adamson, A. W.
Ding, Y. C.
Steele, L.
Leong, L. A.
Morgan, R.
Wakabayashi, M. T.
Han, E. S.
Dellinger, T. H.
Lin, P. S.
Hakim, A. A.
Wilczynski, S.
Warden, C. D.
Tao, S.
Bedell, V.
Cristea, M. C.
Neuhausen, S. L.
-
Funding
Funding for this research was provided by:
Office of Extramural Research, National Institutes of Health (P30CA033572)
- License Information
-
More Information
Article History
Received: 15 February 2023
Accepted: 7 July 2023
First Online: 17 July 2023
Declarations
:
: All individuals provided written informed consent and were enrolled into the study through a City of Hope Institutional Review Board approved protocol (IRB#12358). All methods were carried out in accordance with relevant guidelines and regulations and experimental protocols were approved through a City of Hope Institutional Review Board approved protocol (IRB#12358).
: Not applicable.
: Both Drs. Wakabayashi and Cristea now work at Regeneron; they worked at City of Hope when the data were generated. Dr. Han receives research funding from Vergent Biosciences. None of the other authors report conflicts of interest.
